Patent · US Active

Compounds and methods for enhancing viral gene transfer to human hematopoietic cells

US10273503B2 · kind B2 · utility

0Cited by
3References
22Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 17, 2015
Grant dateApr 30, 2019
Priority date
Expiry dateSep 17, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/15043
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for enhancing viral gene transfer, such as lentiviral gene transfer, and improving the efficacy of gene delivery to cells such as primitive hematopoietic cells, are described. These methods and compositions are based on the use of pyrimido[4,5-b]indole derivatives. Cell-based compositions and methods useful for therapeutic indications amenable to treatment with gene therapies, including hematopoietic stem cell therapies, are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.